Drugs for HER-2-positive Breast Cancer

1. The EGFR/ErbB Family in Breast Cancer: From Signalling to Therapy
Wolfgang J. Köstler, Yosef Yarden

2. Trastuzumab as Adjuvant Treatment for Early Stage HER-2-positive Breast Cancer
Rupert Bartsch, Guenther G. Steger

3. Trastuzumab Resistance in Breast Cancer
Floriana Morgillo, Michele Orditura, Teresa Troiani, Erika Martinelli, Ferdinando Vita, Fortunato Ciardiello

4. Treatment with Trastuzumab Beyond Progression
Gunter Minckwitz, Cristina Pirvulescu

5. Pertuzumab – a HER-2 Dimerisation Inhibitor – for the Treatment of Breast and Other Cancers
Giulia Bianchi, Luca Gianni

6. Beyond Trastuzumab: Second-Generation Targeted Therapies for HER-2-positive Breast Cancer
Flavio F. Solca, Guenther R. Adolf, Hilary Jones, Martina M. Uttenreuther-Fischer

Avainsanat: Biomedicine, Pharmacology/Toxicology, Oncology, Cancer Research, Antibodies, Immunology, Internal Medicine